Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. A. Villalona-Calero
A Phase I/Ii Study of LY900003, an Antisense Inhibitor of Protein Kinase C- , in Combination With Cisplatin and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I and Pharmacokinetic Study of Mitomycin C and Celecoxib as Potential Modulators of Tumor Resistance to Irinotecan in Patients With Solid Malignancies
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
A Phase I/Ii Study of Weekly Nab-Paclitaxel Plus Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
A Phase II Trial of Cremorphor EL-free Paclitaxel (Genexol-Pm) and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses
British Journal of Cancer
Cancer Research
Oncology
Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
